Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
저자
Boku, N.; Ryu, M. H.; Oh, D-Y.; Oh, S. C.; Chung, H. C.; Lee, K-W.; Omori, T.; Shitara, K.; Sakuramoto, S.; Chung, I. J.; Yamaguchi, K.; Kato, K.; Sym, S. J.; Kadowaki, S.; Tsuji, K.; Chen, J-S.; Bai, L-Y.; Chen, L-T.; Kang, Y-K.